Medtronic India Pvt. Ltd

On December 24, 2025, Medtronic India launched a state-of-the-art Mobile Surgi-skill Lab aimed at expanding access to advanced minimally invasive surgery (MIS) training for young surgeons, particularly in tier-2 and tier-3 cities. The mobile lab brings simulation-based, hands-on training directly to hospitals and medical colleges, helping bridge regional skill gaps, improve surgical outcomes, and strengthen India’s healthcare ecosystem through wider clinical skill development

In April 2025, a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure™ defibrillation lead for placement within the right ventricle. The lead, built on the highly reliable SelectSecure™ Model 3830 pacing lead and delivered via catheter, builds on the Medtronic portfolio of lead solutions designed for precise delivery and placement.

In May 2024, For the second year in a row, Medtronic has achieved the second spot on Fair 360’s 2024 Top 50 Companies for Workplace Fairness, marking our highest ranking ever on this list.

In April, a global leader in healthcare technology, announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain.

In March 2022, Medtronic India launched the MiniMed 780G system in India, which is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people between 7-80 years.

In September 2021, Medtronic India Pvt. Ltd. introduced a surgical robotics experience centre in Gurugram to help clinicians with robotic-assisted surgery technology.

In September 2021, Medtronic India Private Limited collaborated with Sher-I-Kashmir Institute of Medical Sciences (SKIMS) to introduce a new surgical skills lab in Srinagar.

In July 2021, Medtronic India Private Limited introduced the Percept PC Deep Brain Stimulation (DBS) system for movement disorders such as epilepsy and Parkinson’s.

In June 2021, Medtronic India Private Limited announced the launch of Micra AV – a miniaturised, fully self-contained pacemaker that delivers advanced pacing technology to atrioventricular (AV) block patients via a minimally invasive approach.

Launched TYRX Envelope, an absorbable, single-use, antibacterial envelope designed to stabilise a cardiac implantable electronic device (CIED) or implanted neurostimulator while releasing antimicrobial agents over a minimum of seven days.

Apollo Hospitals Group announced a partnership with India Medtronic to integrate artificial intelligence (AI) for advanced stroke management for the first time in India. The USFDA-approved AI platform for stroke diagnosis has been validated by clinical trials

Launched the ‘Sonicision Curved Jaw Cordless Ultrasonic Dissection System’, an ultrasonic dissection device in India.

Announced an investment worth Rs. 1,200 crore (US$ 163.2 million) to expand its R&D centre for a medical device software and engineering solutions facility in Hyderabad, Telangana.

Launched the Mazor Stealth edition, a fully integrated procedural solution for surgical planning, workflow, execution, and confirmation of spine surgeries in India.

Launched the ‘VenaSeal Closure System’, a minimally invasive procedure that uses a proprietary medical adhesive to close the diseased vein in patients with chronic venous disease (CVD).

Company partnered with the Cardiological Society of India to increase awareness of sudden cardiac arrests.

Announced roll-out of low-cost hip and knee programme in India.

Expanded into diabetic care category.

Expanded into spinal care category.

Expanded into the neuro-simulation category.

Introduced prosthetic heart valve.

Created the first battery-operated external pacemaker.

Company founded as a medical equipment repair shop.